---
figid: PMC2694555__CG-9-349_F3
figlink: /pmc/articles/PMC2694555/figure/F3/
number: Fig. (3)
caption: Response to pathway inhibitors of tumor cells depends on the mechanism of
  pathway activation. (a) Tumor cells with EGFR mutation are sensitive to EGFR inhibitor
  gefitinib or erlotinib, whereas those with RAS mutation are resistant to the same
  drug, because RAF-MEK-ERK signaling is not inhibited by the drugs. (b) When the
  PI3K pathway is hyperactivated by PI3K mutation or by PTEN loss, tumor cells are
  sensitive to rapamycin, which inhibits mTOR downstream of the pathway. However,
  the HER2 inhibitor Herceptin cannot stop the deregulated signal, because it does
  not inhibit hyperactivation downstream.
pmcid: PMC2694555
papertitle: Can Systems Biology Understand Pathway Activation? Gene Expression Signatures
  as Surrogate Markers for Understanding the Complexity of Pathway Activation.
reftext: Hiraku Itadani, et al. Curr Genomics. 2008 Aug;9(5):349-360.
pmc_ranked_result_index: '192'
pathway_score: 0.959728
filename: CG-9-349_F3.jpg
figtitle: Response to pathway inhibitors of tumor cells depends on the mechanism of
  pathway activation
year: '2008'
organisms: Homo sapiens
ndex: 238fba0f-deb5-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2694555__CG-9-349_F3.html
  '@type': Dataset
  description: Response to pathway inhibitors of tumor cells depends on the mechanism
    of pathway activation. (a) Tumor cells with EGFR mutation are sensitive to EGFR
    inhibitor gefitinib or erlotinib, whereas those with RAS mutation are resistant
    to the same drug, because RAF-MEK-ERK signaling is not inhibited by the drugs.
    (b) When the PI3K pathway is hyperactivated by PI3K mutation or by PTEN loss,
    tumor cells are sensitive to rapamycin, which inhibits mTOR downstream of the
    pathway. However, the HER2 inhibitor Herceptin cannot stop the deregulated signal,
    because it does not inhibit hyperactivation downstream.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PTEN
  - PIK3CD
  - PIK3R3
  - RAF1
  - AKT2
  - EGFR
  - PIK3CG
  - MAPK1
  - AKT3
  - PIK3CA
  - PIK3CB
  - BRAF
  - ARAF
  - MAP2K2
  - HRAS
  - PIK3R6
  - NRAS
  - AKT1
  - PIK3R4
  - PIK3R5
  - MAPK3
  - MAP2K1
  - KRAS
  - Rapamycin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
chemicals:
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
